Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement ...
Explore the challenges faced by families in Kerala caring for children with chronic disabilities and the urgent need for ...
Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s ...
Under an expanded medical marijuana program that takes effect today in Georgia, people who qualify for a medical cannabis ...
Pacira to receive up to $140 million with $70 million upfront and up to an additional $70 million in potential future revenue-based milestone ...
Touchpoints in Manchester offers post-acute, rehabilitative and skilled nursing care. Beyond short-term rehabilitation, services and programs include a dynamic behavioral health program based on a ...
Zacks Investment Research on MSN
Pacira to divest iovera business to Zimmer Biomet in up to $140M deal
Pacira BioSciences PCRX is reshaping its business through an agreement to divest its iovera medical device franchise to Zimmer Biomet ZBH for up to $140 million. The deal marks another step in ...
The first time Amy Degrado tried to lift the weight of a feed bag again, it didn’t happen on her farm. It happened inside a ...
4don MSN
Medicare will start covering obesity drugs for the first time. Here's what patients should know
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...
Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results